Objectives: To investigate the association between the HL gene (LIPC) polym
orphism, plasma lipid levels and coronary artery disease (CAD).
Design and methods: One hundred thirty-seven subjects with CAD and 124 age-
matched controls were examined by polymerase chain reaction (PCR). The PCR
products were analyzed for LIPC genotyping by enzyme digestion.
Results: The allele frequencies of the three polymorphisms in the LIPC gene
were not significantly different between the controls and CAD patients. Th
e + allele of the -514 promoter polymorphism was associated with higher tot
al cholesterol (p = 0.05), apolipoprotein (apo) Al (p = 0.04) levels in the
men of the normal group, and the apoB level (p = 0.03) in the women of the
CAD group without allele effect. The allele frequencies of the -250 and -5
14 promoter polymorphisms of Koreans were significantly different from thos
e of the white and African American populations studied (p < 0.05).
Conclusions: The -514 promoter polymorphism may fluctuate on the lipid leve
ls due to linkage disequilibria with other polymorphisms of the LIPC gene o
r nearby genes. The difference of the -250 promoter allele frequencies amon
g the different populations may partially explain the variation of the HDL
levels in ethnic groups. To elucidate the more exact associations of LIPC p
olymorphism with the plasma lipid levels, the precise biochemical mechanism
s of the LIPC alleles are required. Copyright (C) 2000 The Canadian Society
of Clinical Chemists.